Skip to content
Company Analysis

Baird Medical Investment Holdin BDMD

A comprehensive view of key metrics, scores, and financial health for Baird Medical Investment Holdin

Overview of Baird Medical Investment Holdings Limited

BDMD NCM
Healthcare Medical Devices Micro Cap
Baird Medical Investment Holdings Limited (BDMD), is a Micro Cap company, in the Medical Devices industry, last closed at $2.40, about 4.2% undervalued vs fair value, -59.8% 1Y return, ranked 884/1111 in sector.
$2.40
8.60%
As of March 13, 2026
Previous close • Vol 90d: 149.0%
52-Week Range
Market Cap
$88.14M
Enterprise Value
$108.53M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Baird Medical Investment Holdin.

Top Beats

Quick Facts

Website https://bairdmed.com
HQ Guangzhou
Employees 143
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$2
$3
$3
Current: $2.40 +4% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$37.0M
17.7%%
Gross Profit
$32.7M
19.9%%
Operating Income
$15.3M
21%%
Net Income
$12.5M
18.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
-73.6%
Poor

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Baird Medical Investment Holdin's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
75
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Strong
89
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing BDMD's balance between Growth (26.4%), Profitability (46.8%), and Safety (26.9%). Growth 26% Safety 27% Profitability 47%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

49th percentile vs peers
49
Key Signals
Rev Growth YoY 17.7% 67p Revenue CAGR 3Y 10.1% 50p EPS Growth YoY 17.8% 43p EPS CAGR 3Y 7.2% 45p TSR -71.5% 10p
Strengths
  • Interest Coverage Ratio in top 20% of peers (25.43, 90th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Operating Margin in top 20% of peers (41.3%, 99th percentile)
  • Roic in top 20% of peers (22.7%, 91th percentile)
Risks

No significant risks identified for this axis.

Profitability

87th percentile vs peers
88
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

50th percentile vs peers
50
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Baird Medical Investment Holdin.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$2.50
- - -
+4.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info